Vasoactive Intestinal Peptide (VIP+) Interneurons

Vasoactive Intestinal Peptide-Positive (VIP+) Interneurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Vasoactive Intestinal Peptide (VIP+) Interneurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0002269](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002269)</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Aviptadil</td>
<td>VPAC1/2</td>
</tr>
<tr>
<td class="label">Ro 25-1553</td>
<td>VPAC2</td>
</tr>
<tr>
<td class="label">BAY 55-9837</td>
<td>VPAC2</td>
</tr>
<tr>
<td class="label">Lys15, Arg16, Lys27VIP(1-7)</td>
<td>VPAC1</td>
</tr>
</table>

Overview

Vasoactive Intestinal Peptide-Positive (VIP+) Interneurons describes a neural cell population with specific vulnerability or functional significance in neurodegenerative disease. This page covers cell morphology, molecular markers, connectivity, and disease-specific pathological changes.

Vasoactive Intestinal Peptide-Positive (VIP+) Interneurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Vasoactive Intestinal Peptide (VIP+) Interneurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0002269](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002269)</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Aviptadil</td>
<td>VPAC1/2</td>
</tr>
<tr>
<td class="label">Ro 25-1553</td>
<td>VPAC2</td>
</tr>
<tr>
<td class="label">BAY 55-9837</td>
<td>VPAC2</td>
</tr>
<tr>
<td class="label">Lys15, Arg16, Lys27VIP(1-7)</td>
<td>VPAC1</td>
</tr>
</table>

Overview

Vasoactive Intestinal Peptide-Positive (VIP+) Interneurons describes a neural cell population with specific vulnerability or functional significance in neurodegenerative disease. This page covers cell morphology, molecular markers, connectivity, and disease-specific pathological changes.

Vasoactive intestinal peptide-positive (VIP+) interneurons are a specialized class of cortical GABAergic neurons that comprise approximately 10-15% of cortical interneurons. Unlike PV+ and SST+ interneurons that directly inhibit pyramidal cells, VIP+ interneurons primarily target other interneurons—particularly SST+ Martinotti cells—creating a disinhibitory circuit that is crucial for attention, arousal, and top-down processing. Their unique role in gating dendritic inhibition makes them essential for cognitive flexibility and vulnerable in neurodegenerative diseases.

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Classification & Lineage

• Parent Classification: Cortical interneuron
• Full Lineage: Neuron > GABAergic > Cortical interneuron > VIP+
• Brain Regions: Cerebral cortex (layers 2/3), Hippocampus

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0002269)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002269)
• [OBO Foundry (CL:0002269)](http://purl.obolibrary.org/obo/CL_0002269)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Molecular Identity and Markers

Neuropeptide Expression

• Vasoactive Intestinal Peptide (VIP): 28-amino acid neuropeptide with neuromodulatory functions
• Calretinin: Calcium-binding protein co-expressed in 70-80% of VIP+ cells
• Cholecystokinin (CCK): Co-expressed in subset of VIP+ neurons
• Substance P: Occasional co-expression in specific subtypes

Transcription Factors

• Dbx1: Dorsal progenitor origin marker (caudal ganglionic eminence)
• COUP-TFII: Specifies VIP+ interneuron lineage
• Prox1: Present in CGE-derived interneurons
• Sp8: Transcription factor for VIP+ specification

Ion Channels and Receptors

• 5-HT3A Receptors: Serotonin-gated ion channel (diagnostic marker)
• α7 Nicotinic Receptors: Cholinergic modulation
• Cholinergic Muscarinic Receptors: M1/M2 for arousal modulation
• NMDA/AMPA Receptors: Glutamatergic excitation

GABAergic Markers

• GAD65/GAD67: GABA synthesis enzymes
• VGAT: Vesicular GABA transporter
• GABA-A Receptor Subunits: α1, β2/3, γ2 on target cells

Morphological Subtypes

Bipolar/Bitufted Cells

• Dendrites: Vertically oriented, spanning multiple layers
• Axons: Local ramification with some long-range projections
• Distribution: Layers 2-6, most common in layers 2/3

Multipolar Cells

• Dendrites: Radial orientation
• Axons: Dense local plexus
• Distribution: All cortical layers

Canopy Cells

• Characteristics: Axons restricted to layer 1
• Function: Modulate distal dendritic activity
• Distribution: Superficial layers

Long-Range VIP+ Neurons

• Projections: Extend across cortical areas
• Function: Interareal coordination of disinhibition
• Distribution: Deeper cortical layers

Electrophysiological Properties

Discharge Patterns

• Irregular Spiking: Interspike interval variability
• Adapting: Frequency adaptation during sustained firing
• Burst Firing: Some VIP+ neurons exhibit bursting
• Late Spiking: Delayed action potential onset in some subtypes

Membrane Properties

• Resting Potential: -55 to -60 mV (relatively depolarized)
• Input Resistance: High (300-500 MΩ)
• Rheobase: Low threshold for activation
• Sag: Prominent H-current-mediated sag during hyperpolarization

Synaptic Dynamics

• Weak Inhibition: Smaller IPSCs than PV+ or SST+ neurons
• Paired-Pulse Facilitation: Common at VIP terminals
• Volume Transmission: Possible extrasynaptic GABA release

Network Functions

Disinhibitory Microcircuit

Disinhibition Mechanism:

Attention and Arousal

Cholinergic Modulation:

• Basal forebrain cholinergic input activates VIP+ neurons
• VIP+ disinhibition enables attentional selection
• VIP+ activity increases during focused attention tasks

• Locus coeruleus input enhances VIP+ excitability
• Arousal-related network reconfiguration via VIP+ cells
• Wakefulness-associated disinhibitory tone

State-Dependent Processing

• Active Processing: VIP+ neurons highly active, dendritic disinhibition
• Quiet Wakefulness: Reduced VIP activity, balanced inhibition
• Sleep: VIP+ activity suppressed, enhanced SST+ dendritic inhibition

Social and Emotional Processing

• Default Mode Network: VIP+ modulation of DMN activity
• Social Cognition: Disinhibitory control in social circuits
• Emotional Regulation: VIP+ neurons in amygdala circuits

Neurodegenerative Disease Mechanisms

Alzheimer's Disease

Cholinergic Hypothesis Connection:

• VIP+ interneurons are primary targets of cholinergic input
• Basal forebrain degeneration → loss of VIP+ activation
• Impaired attention and arousal in AD

• Reduced VIP+ function leads to excessive SST+ inhibition
• Dendritic processing deficits in hippocampus
• Memory encoding impairment

• VIP has anti-inflammatory and neuroprotective properties
• VIP receptors (VPAC1/2) protect against Aβ toxicity
• Reduced VIP levels in AD brain

Parkinson's Disease

Dopamine-ACh Interactions:

• Dopamine modulates cholinergic interneurons
• PD dopamine loss affects VIP+ neuron activation
• Attention deficits in PD linked to VIP+ dysfunction

• Impaired VIP+ function contributes to executive dysfunction
• Reduced cognitive flexibility from disinhibitory circuit disruption
• Attention and working memory deficits

Frontotemporal Dementia

Behavioral Variant FTD:

• VIP+ interneuron loss in frontal and temporal cortex
• Impaired social disinhibition circuits
• Loss of behavioral flexibility

• VIP+ neurons vulnerable to C9orf72-mediated toxicity
• Dipeptide repeat proteins affect VIP+ function

Huntington's Disease

Striatal VIP+ Interneurons:

• Small population but functionally important
• Vulnerable to mutant huntingtin
• Contribute to movement and cognitive symptoms

Amyotrophic Lateral Sclerosis

Cortical Inhibition Changes:

• Limited data on VIP+ neurons in ALS
• Potential compensatory changes in disinhibitory circuits
• May contribute to motor cortex hyperexcitability

Therapeutic Approaches

VIP Receptor Agonists

Cholinergic Enhancement

• Acetylcholinesterase Inhibitors: Donepezil, rivastigmine for AD
• Alpha-7 Nicotinic Agonists: Enhance VIP+ activation
• Muscarinic Modulators: M1 positive allosteric modulators

Serotonergic Modulation

• 5-HT3 Agonists: Direct VIP+ activation
• SSRIs: Indirect enhancement via 5-HT availability
• Psilocybin/5-HT2A: Potential VIP+ circuit modulation

Neuroprotective Strategies

• VIP Gene Therapy: AAV-mediated VIP expression
• Anti-inflammatory: Reduce neuroinflammation affecting VIP+ cells
• Mitochondrial Support: Protect VIP+ neurons from energy deficits

Biomarkers and Diagnostics

CSF VIP Levels

• Reduced in AD and other dementias
• Correlation with cognitive decline
• Potential therapeutic target

Neuroimaging

• GABA-MRS: Indirect VIP+ function assessment
• Functional connectivity: Disinhibitory network integrity
• PET: VIP receptor ligand development

Electrophysiology

• EEG gamma power: Reflects VIP-PV circuit function
• Attention-related potentials: VIP+ circuit biomarkers
• Sleep architecture: VIP+ modulation of sleep states

Brain Atlas Resources

• [Allen Cell Type Atlas - VIP](https://celltypes.brain-map.org/)
• [Allen Human Brain Atlas - Cell Type Data](https://human.brain-map.org/microarray)
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/)
• [BrainSpan - Brain Development](https://brainspan.org/)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/genes/ar)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

External Database Links

• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas) - Cell type taxonomy
• [Allen Cell Type Atlas](https://celltypes.brain-map.org/) - Single-cell expression data
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/) - Mouse brain reference data